Total Valuation
Omega Diagnostics has a market cap or net worth of €4.29M. The enterprise value is €1.89.
Market Cap€4.29M
Enterprise Value€1.89
Share Statistics
Omega Diagnostics has 237,950,650 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding237,950,650
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Omega Diagnostics’s return on equity (ROE) is -1.03 and return on invested capital (ROIC) is -17.76%.
Return on Equity (ROE)-1.03
Return on Assets (ROA)-0.78
Return on Invested Capital (ROIC)-17.76%
Return on Capital Employed (ROCE)-0.18
Revenue Per Employee82.06K
Profits Per Employee-68.54K
Employee Count85
Asset Turnover0.94
Inventory Turnover4.12
Valuation Ratios
The current PE Ratio of Omega Diagnostics is ―. Omega Diagnostics’s PEG ratio is 0.00160.
PE Ratio―
PS Ratio0.63
PB Ratio0.77
Price to Fair Value0.77
Price to FCF-3.17
Price to Operating Cash Flow-3.25
PEG Ratio0.00160
Income Statement
In the last 12 months, Omega Diagnostics had revenue of 6.97M and earned -5.83M in profits. Earnings per share was -0.02.
Revenue6.97M
Gross Profit4.28M
Operating Income-1.04M
Pretax Income-4.42M
Net Income-5.83M
EBITDA-392.00K
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -1.13M and capital expenditures -253.00K, giving a free cash flow of -1.39M billion.
Operating Cash Flow-1.13M
Free Cash Flow-1.39M
Free Cash Flow per Share>-0.01
Dividends & Yields
Omega Diagnostics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.51
52-Week Price Change-50.00%
50-Day Moving Average0.01
200-Day Moving Average0.01
Relative Strength Index (RSI)43.95
Average Volume (3m)0.00
Important Dates
Omega Diagnostics upcoming earnings date is Nov 19, 2026, TBA (Confirmed).
Last Earnings DateSep 8, 2026
Next Earnings DateNov 19, 2026
Ex-Dividend Date―
Financial Position
Omega Diagnostics as a current ratio of 3.40, with Debt / Equity ratio of 2.20%
Current Ratio3.40
Quick Ratio3.00
Debt to Market Cap0.02
Net Debt to EBITDA6.41
Interest Coverage Ratio-80.38
Taxes
In the past 12 months, Omega Diagnostics has paid 1.41M in taxes.
Income Tax1.41M
Effective Tax Rate-0.32
Enterprise Valuation
Omega Diagnostics EV to EBITDA ratio is -4.82, with an EV/FCF ratio of -1.36.
EV to Sales0.27
EV to EBITDA-4.82
EV to Free Cash Flow-1.36
EV to Operating Cash Flow-1.67
Balance Sheet
Omega Diagnostics has €2.64M in cash and marketable securities with €125.00K in debt, giving a net cash position of €2.51M billion.
Cash & Marketable Securities€2.64M
Total Debt€125.00K
Net Cash€2.51M
Net Cash Per Share€0.01
Tangible Book Value Per Share€0.02
Margins
Gross margin is 61.32%, with operating margin of -14.98%, and net profit margin of -83.53%.
Gross Margin61.32%
Operating Margin-14.98%
Pretax Margin-63.37%
Net Profit Margin-83.53%
EBITDA Margin-5.62%
EBIT Margin-14.98%
Analyst Forecast
The average price target for Omega Diagnostics is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-18.45%
EPS Growth Forecast-455.70%